Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.

NCT03245736 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovary Cancer
Cervix Cancer
Endometrium Cancer
Bladder Cancer
Prostate Cancer
Esophagus Cancer
Lung Cancer, Nonsmall Cell
Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Tisotumab Vedotin

Sponsor

Seagen Inc.

Collaborators

[object Object]